Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pancreatitis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 23 articles:
HTML format
Text format



Single Articles


    June 2018
  1. VAN BRUNSCHOT S, van Santvoort H, Besselink M, Fockens P, et al
    Infected necrotising pancreatitis: antibiotic administration remains the first step - Authors' reply.
    Lancet. 2018;391:2502.
    PubMed     Text format    


  2. NESSELER N, Ross JT, Malledant Y
    Infected necrotising pancreatitis: antibiotic administration remains the first step.
    Lancet. 2018;391:2501-2502.
    PubMed     Text format    


    November 2017
  3. ADLER DG
    Surgery versus endoscopy for patients with infected pancreatic necrosis.
    Lancet. 2017 Nov 3. pii: S0140-6736(17)32344.
    PubMed     Text format    


  4. VAN BRUNSCHOT S, van Grinsven J, van Santvoort HC, Bakker OJ, et al
    Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial.
    Lancet. 2017 Nov 3. pii: S0140-6736(17)32404.
    PubMed     Text format     Abstract available


    September 2017
  5. DIENER MK, Huttner FJ, Kieser M, Knebel P, et al
    Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial.
    Lancet. 2017;390:1027-1037.
    PubMed     Text format     Abstract available


  6. BELLIN MD, Beilman GJ
    Surgical trials for chronic pancreatitis.
    Lancet. 2017;390:1007-1008.
    PubMed     Text format    


    August 2017
  7. BOECK S, Heinemann V
    Improving post-surgical management of resected pancreatic cancer.
    Lancet. 2017;390:847-848.
    PubMed     Text format    


    January 2017
  8. NEOPTOLEMOS JP, Palmer DH, Ghaneh P, Psarelli EE, et al
    Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
    Lancet. 2017 Jan 24. pii: S0140-6736(16)32409.
    PubMed     Text format     Abstract available


  9. DEPLANQUE G, Demartines N
    Pancreatic cancer: are more chemotherapy and surgery needed?
    Lancet. 2017 Jan 24. pii: S0140-6736(17)30126.
    PubMed     Text format    


    June 2016
  10. KO AH
    Raising the bar for the adjuvant treatment of pancreatic cancer.
    Lancet. 2016 Jun 2. pii: S0140-6736(16)30680.
    PubMed     Text format    


  11. UESAKA K, Boku N, Fukutomi A, Okamura Y, et al
    Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
    Lancet. 2016 Jun 2. pii: S0140-6736(16)30583.
    PubMed     Text format     Abstract available


    May 2016
  12. MILOSEVIC I, Drysdale H, Goldacre B
    Nanoliposomal irinotecan in metastatic pancreatic cancer.
    Lancet. 2016;387:1997.
    PubMed     Text format    


  13. CHEN LT, Wang-Gillam A, Von Hoff DD, Bayever E, et al
    Nanoliposomal irinotecan in metastatic pancreatic cancer - Authors' reply.
    Lancet. 2016;387:1997.
    PubMed     Text format    


    April 2016
  14. LUO H, Zhao L, Leung J, Zhang R, et al
    Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial.
    Lancet. 2016 Apr 28. pii: S0140-6736(16)30310.
    PubMed     Text format     Abstract available


  15. DE MESTRAL C
    Simple pharmacological prophylaxis for post-ERCP pancreatitis.
    Lancet. 2016 Apr 28. pii: S0140-6736(16)30312.
    PubMed     Text format    


    February 2016
  16. MAJUMDER S, Chari ST
    Chronic pancreatitis.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00097.
    PubMed     Text format     Abstract available


    January 2016
  17. KAMISAWA T, Wood LD, Itoi T, Takaori K, et al
    Pancreatic cancer.
    Lancet. 2016 Jan 29. pii: S0140-6736(16)00141.
    PubMed     Text format     Abstract available


    November 2015
  18. OETTLE H, Lehmann T
    Gemcitabine-resistant pancreatic cancer: a second-line option.
    Lancet. 2015 Nov 23. pii: S0140-6736(15)01035.
    PubMed     Text format    


  19. WANG-GILLAM A, Li CP, Bodoky G, Dean A, et al
    Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
    Lancet. 2015 Nov 20. pii: S0140-6736(15)00986.
    PubMed     Text format     Abstract available


    September 2015
  20. DA COSTA DW, Bouwense SA, Schepers NJ, Besselink MG, et al
    Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial.
    Lancet. 2015;386:1261-8.
    PubMed     Text format     Abstract available


  21. DE MESTRAL C, Nathens AB
    Cholecystectomy in mild gallstone pancreatitis: don't defer.
    Lancet. 2015;386:1218-9.
    PubMed     Text format    


    February 2015
  22. KHALED YS, Wright K, Melcher A, Jayne D, et al
    Anti-cancer effects of oncolytic viral therapy combined with photodynamic therapy in human pancreatic cancer cell lines.
    Lancet. 2015;385 Suppl 1:S56.
    PubMed     Text format     Abstract available


  23. FRAMPTON AE, Castellano L, Colombo T, Giovannetti E, et al
    Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression.
    Lancet. 2015;385 Suppl 1:S37.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: